Chanelle Launches Ketamidor® - A Versatile Veterinary Anaesthetic

Ketamidor pack shot Chanelle has launched Ketamidor® 100 mg/ml Solution for Injection in the UK and Ireland. With ketamine as the active ingredient, the new product provides a versatile addition to anaesthetic regimes. Able to be used in combination with other widely used anaesthetics and sedatives, Ketamidor® 100 mg/ml Solution for Injection also has analgesic properties that make it particularly beneficial to include in anaesthetic protocols when carrying out painful surgical procedures. Ketamidor® 100mg/ml Solution for Injection can be used in cattle and pigs and has a zero day withdrawal period for milk and meat, allowing high welfare standards to be maintained without compromising economic returns. After 50 years of tried and trusted use of ketamine in human and veterinary medicine, it is now experiencing a resurgence of interest as the analgesic properties and minimal impact on spontaneous respiration becomes increasingly appreciated.¹ Angela Wilkin is Chanelle UK Sales and Marketing Manager, “Ketamidor® makes a great addition to our portfolio of pain management products. Our territory managers are looking forward to speaking to those vets who are already accustomed to using ketamine and those that may be considering adding it to their current protocols.” Ketamidor® 100 mg/ml Solution for Injection contains ketamine hydrochloride. Legal category UK: POM-V Vm 22080/4004 For full contraindications and warnings please refer to the product SPC IRELAND VPA NO. 10801/006/001 VPO Veterinary Practioner Only ReferencePai, A. and Heining, M. Ketamine. Continuing Education in Anaesthesia, Critical Care and Pain. Volume 2 Number 2 2007

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology